Use of retinal ischemic perivascular lesions (RIPLS) as a biomarker for cardiovascular disease - a systematic review and meta-analysis

视网膜缺血性血管周围病变(RIPLS)作为心血管疾病生物标志物的应用——系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: This study aims to evaluate the association between retinal ischemic perivascular lesions (RIPLs) detected by optical coherence tomography (OCT) and the risk of all-cause cardiovascular morbidity. METHODS: A systematic review and meta-analysis were performed. PubMed MEDLINE, Scopus, and Cochrane CENTRAL were searched for observational studies from January 2015 to March 2025 assessing RIPLs and cardiovascular disease (CVD). Odds ratios (ORs) with 95% confidence intervals (CIs) were pooled using a random-effects model. RESULTS: Of 61 studies screened, six met inclusion criteria and four were included in the meta-analysis (total n = 710). The pooled OR for CVD morbidity associated with RIPLs was 2.8 (95% CI: 1.98–3.95), indicating over a twofold increased risk. Heterogeneity was minimal (I² = 0%). CONCLUSIONS: RIPLs detected by OCT are significantly associated with increased cardiovascular risk. Due to OCT’s non-invasive and accessible nature, RIPLs may be a useful screening biomarker for early detection of CVD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40942-025-00782-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。